×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Krsnaa Diagnostics Limited | 1796.13 | 195.62 | 1756.15 | 6 | 2,688 | 33.5 |
| INDOCO REMEDIES LTD. | 3981.1 | -280.6 | 3925.3 | -3.04 | 2589 | |
| Shalby Limited | 2421.77 | 256.95 | 2366.54 | 2.39 | 2531 | 32.1 |
Krsnaa Diagnostics Limited, with Security Code 543328, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 115.7 | 115.9 | 132.3 | 146.9 | 151.6 | 159.3 | 163.2 | 178.7 | 165.2 | 175.6 |
| Expenses | 82.0 | 90.8 | 100.1 | 114.3 | 113.4 | 116.1 | 120.2 | 126.2 | 117.3 | 125.5 |
| Operating Profit | 33.8 | 25.1 | 32.2 | 32.5 | 38.2 | 43.3 | 43.0 | 52.5 | 47.9 | 50.1 |
| OPM % | 29.19% | 21.66% | 24.33% | 22.16% | 25.18% | 27.16% | 26.34% | 29.36% | 29% | 28.53% |
| Other Income | 4.6 | 5.9 | 4.2 | 4.2 | 4.1 | 4.3 | 7.3 | 4.6 | 9.3 | 4.0 |
| Interest | 2.3 | 2.2 | 2.0 | 3.1 | 4.1 | 7.3 | 5.3 | 6.4 | 6.1 | 6.2 |
| Depreciation | 13.9 | 14.6 | 15.7 | 19.5 | 21.2 | 18.1 | 21.5 | 22.2 | 22.7 | 21.5 |
| Profit before tax | 22.2 | 14.2 | 18.7 | 14.2 | 16.9 | 22.2 | 23.5 | 28.5 | 28.4 | 26.3 |
| Tax % | -23.9% | -16.9% | -18.5% | -20.3% | -19.5% | 17% | 22.7% | -22.9% | -23.9% | 25.7% |
| Net Profit | 16.9 | 11.8 | 15.3 | 11.3 | 13.6 | 18.4 | 18.2 | 22.0 | 21.6 | 19.6 |
| EPS in Rs | 5.24 | 3.67 | 4.71 | 3.48 | 4.16 | 5.61 | 5.54 | 6.64 | 6.54 | 6 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 118.1 | 133.2 | 139.6 | 155.4 | 158.3 | 166.3 | 170.2 | 186.3 | 174.5 | 186.1 |
| Expenses | 88.7 | 98.7 | 108.2 | 123.7 | 120.9 | 122.6 | 127.6 | 136.9 | 129.4 | 133.0 |
| Operating Profit | 29.4 | 34.5 | 31.4 | 31.8 | 37.4 | 43.7 | 42.7 | 49.4 | 45.1 | 53.0 |
| OPM % | 24.9% | 25.88% | 22.47% | 20.45% | 23.62% | 26.28% | 25.06% | 26.51% | 25.83% | 28.51% |
| Other Income | 4.5 | 5.9 | 4.2 | 4.2 | 4.1 | 4.3 | 7.3 | 4.6 | 9.2 | 4.4 |
| Interest | 2.3 | 2.2 | 2.0 | 3.1 | 4.1 | 7.3 | 5.3 | 6.4 | 6.1 | 6.8 |
| Depreciation | 13.9 | 14.6 | 15.7 | 19.5 | 21.2 | 18.1 | 21.5 | 22.2 | 22.7 | 22.0 |
| Profit before tax | 17.8 | 23.6 | 17.9 | 13.4 | 16.1 | 22.6 | 23.2 | 25.4 | 25.5 | 28.7 |
| Tax % | -23.3% | -19.8% | -18.2% | -21.8% | -19.4% | -17.2% | -22.8% | 22.9% | 23.8% | -27.6% |
| Net Profit | 13.6 | 18.9 | 14.6 | 10.5 | 13.0 | 18.7 | 17.9 | 19.6 | 19.4 | 20.7 |
| EPS in Rs | 4.24 | 5.88 | 4.52 | 3.23 | 3.97 | 5.7 | 5.46 | 5.92 | 5.88 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 5% |
| TTM: | 41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 6% |
| 1 Year: | 9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 16% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 4% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 6% |
| 1 Year: | 9% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|